Skip to main content
CRIS logo

CRIS · Curis Inc · Executive Compensation

Track CRIS — free
$0.43 -0.04 (-9.03%) At close · Nov 20 Play latest call Q3 2026 earnings call transcript
Market Cap
$4.06M
Shares
9.51M
Volume · Nov 20 531.09K Avg daily vol (3M) 4.27M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2023
Executive Total
Jonathan Zung $882,415
Fiscal 2022
Executive Total
Diantha Duvall $786,109
Fiscal 2021
Executive Total
James E. Dentzer $3,390,187
William E. Steinkrauss $1,899,445
Robert Martell $1,502,517
Fiscal 2020
Executive Total
James E. Dentzer $1,672,849
Robert Martell $961,345
William E. Steinkrauss $891,755
Fiscal 2019
Executive Total
James E. Dentzer $1,557,773
Robert Martell $776,494
William E. Steinkrauss $690,165
Fiscal 2018
Executive Total
James E. Dentzer $1,964,736
Robert Martell $940,469
Fiscal 2017
Executive Total
James E. Dentzer $1,578,961

Executive changes

Person Change Filed
Marc Rubin, M.D. Appointed 2025-05-22
John A. Hohneker, M.D. Appointed 2025-05-22
James E. Dentzer Already on the board
Since at least 2021: re-election or new board role
2024-05-23
Anne E. Borgman, M.D. Appointed 2024-05-23
Lori A. Kunkel, M.D. Resigned 2022-09-22
Bill Steinkrauss Resigned 2022-08-04
Diantha Duvall Appointed 2022-08-04
William Steinkrauss
“Mr. Steinkrauss’s decision to leave his position at Curis is not the result of any dispute or disagreement with the Company or its Board of Directors regarding the Company’s financial reporting or disclosures, accounting policies or procedures or operating practices.”
Resigned 2022-06-30
John A. Hohneker, M.D. Appointed 2021-12-06

Leadership

Key facts CIK 1108205 CUSIP 231269408 13F (30d) 52 filings 29 filers Visit website Investor relations